Assyro AI

FDA Orange Book · active-ingredient family

Reserpine

Reserpine is approved as 17 brand and 23 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:RESERPINE · NDA 009838

17

Brand (NDA)

23

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · elixir, injectable, tablet

ProductApplicantApplicationTEApproved
RESERPINERLD×2SANDOZNDA 009838—Approved Prior to Jan 1, 1982
SERPASIL×4NOVARTISNDA 009115—Approved Prior to Jan 1, 1982
SANDRILLILLYNDA 010012—Approved Prior to Jan 1, 1982
SERPASILNOVARTISNDA 009434—Approved Prior to Jan 1, 1982
HISERPIA×2BOWMAN PHARMSNDA 009631—Approved Prior to Jan 1, 1982
RAU-SED×4BRISTOL MYERS SQUIBBNDA 009357—Approved Prior to Jan 1, 1982
RESERPINE×2BUNDYNDA 009663—Approved Prior to Jan 1, 1982
RESERPINE×2CYCLENDA 009859—Approved Prior to Jan 1, 1982
RESERPINE×4EVERYLIFENDA 010441—Approved Prior to Jan 1, 1982
RESERPINE×2IMPAX LABSNDA 009627—Approved Prior to Jan 1, 1982
RESERPINE×2IVAX SUB TEVA PHARMSNDA 011185—Approved Prior to Jan 1, 1982
RESERPINE×2VALEANT PHARM INTLNDA 009667—Approved Prior to Jan 1, 1982
SANDRIL×2LILLYNDA 009376—Approved Prior to Jan 1, 1982
SERPALAN×2LANNETTNDA 010124—Approved Prior to Jan 1, 1982
SERPANRAY×3PANRAYNDA 009391—Approved Prior to Jan 1, 1982
SERPATE×2VALENDA 009453—Approved Prior to Jan 1, 1982
SERPIVITEVITARINENDA 009645—Approved Prior to Jan 1, 1982

Generic (ANDA) products (23)

ProductApplicantApplicationTEApproved
RESERPINETEVAANDA 089020—Mar 07, 1985
RESERPINETEVAANDA 089019—Mar 07, 1985
RESERPINEBARRANDA 080721—Approved Prior to Jan 1, 1982
RESERPINE×2BELL PHARMAANDA 083058—Approved Prior to Jan 1, 1982
RESERPINE×2ELKINS SINNANDA 083145—Approved Prior to Jan 1, 1982
RESERPINE×3HALSEYANDA 080457—Approved Prior to Jan 1, 1982
RESERPINE×3HIKMA INTL PHARMSANDA 080975—Approved Prior to Jan 1, 1982
RESERPINE×2MARSHALL PHARMAANDA 080492—Approved Prior to Jan 1, 1982
RESERPINE×2MK LABSANDA 080525—Approved Prior to Jan 1, 1982
RESERPINEMYLANANDA 084974—Approved Prior to Jan 1, 1982
RESERPINEPHARMAVITEANDA 084663—Approved Prior to Jan 1, 1982
RESERPINE×2PUREPAC PHARMANDA 080753—Approved Prior to Jan 1, 1982
RESERPINEPVT FORMANDA 086117—Approved Prior to Jan 1, 1982
RESERPINE×2PVT FORMANDA 080582—Approved Prior to Jan 1, 1982
RESERPINEPVT FORMANDA 085775—Approved Prior to Jan 1, 1982
RESERPINEREXALLANDA 080637—Approved Prior to Jan 1, 1982
RESERPINESOLVAYANDA 080446—Approved Prior to Jan 1, 1982
RESERPINETABLICAPSANDA 085207—Approved Prior to Jan 1, 1982
RESERPINEWATSON LABSANDA 080679—Approved Prior to Jan 1, 1982
RESERPINEWATSON LABSANDA 080393—Approved Prior to Jan 1, 1982
RESERPINEWATSON LABSANDA 085401—Approved Prior to Jan 1, 1982
RESERPINEWATSON LABSANDA 080749—Approved Prior to Jan 1, 1982
RESERPINE×3WHITEWORTH TOWN PLSNANDA 080723—Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Reserpine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo